As of Jun 27
| -0.06 / -2.55%|
The 2 analysts offering 12-month price forecasts for BioTime Inc have a median target of 7.50, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +227.51% increase from the last price of 2.29.
The current consensus among 2 polled investment analysts is to Buy stock in BioTime Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.